Xtant Medical

Xtant Medical Enters into Restructuring and Exchange Agreement with All Holders of Outstanding Convertible Notes

Conversion of $1.627M (plus interest) of convertible notes into common stock Exchange of $70.238M (plus interest) of convertible notes into common stock Upon stockholder approval, amendment of Certificate of Incorporation to effect reverse stock split of common stock Private placement of approximately $6.809M of common stock Completion of transaction anticipated to allow Xtant to meet liquidity needs and reposition itself for long-term growth. BELGRADE, Mont., Jan. 18, 2018 (GLOBE NEWSWIRE) — Xtantâ„¢ Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, announced that it has entered into a Restructuri…